Atypical kinases are a group of protein kinases that do not fit into the traditional classification of serine/threonine or tyrosine kinases. Atypical kinases are characterized by a unique catalytic domain that is structurally distinct from other protein kinases.
Atypical
- CPI203, Inhibitor of bromodomain containing 4
Cas#:1446144-04-2
- I-BRD9, Inhibitor of bromodomain containing 9
Cas#:1714146-59-4
- VE-821, Inhibitor of ATR serine/threonine kinase
Cas#:1232410-49-9
- PF-04691502, PI3-kinase class I inhibitor
Cas#:1013101-36-4
- AZD8055, Serine/threonine-protein kinase mTOR inhibitor
Cas#:1009298-09-2
- AZD2014, Serine/threonine-protein kinase mTOR inhibitor
Cas#:1009298-59-2
- Everolimus, FK506-binding protein 1A inhibitor
Cas#:159351-69-6
- Mivebresib, Inhibitor of bromodomain containing 4
Cas#:1445993-26-9
- BEZ235, PI3-kinase class I inhibitor
Cas#:915019-65-7
- AZ20, Inhibitor of ATR serine/threonine kinase
Cas#:1233339-22-4
- Berzosertib, Serine-protein kinase ATR inhibitor
Cas#:1232416-25-9
- GDC-0980 (RG7422), PI3-kinase class I inhibitor
Cas#:1032754-93-0
- Serabelisib, PI3-kinase p110-alpha subunit inhibitor
Cas#:1268454-23-4